234
Views
5
CrossRef citations to date
0
Altmetric
Review

Acute ischemic stroke: improving access to intravenous tissue plasminogen activator

, &
Pages 277-287 | Received 08 Nov 2019, Accepted 20 Apr 2020, Published online: 05 May 2020

References

  • Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the global burden of disease study 2010. Lancet. 2014 Jan 18;383(9913):245–254.
  • National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24): 1581–1587.
  • Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317–1329.
  • Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second european-australasian acute stroke study investigators. Lancet. 1998 Oct 17;352(9136):1245–1251.
  • Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999 Dec 1;282(21):2019–2026.
  • Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29;384(9958):1929–1935.
  • Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr 23;387(10029):1723–1731.
  • Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018 Jan 4;378(1):11–21.
  • Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018 Feb 22;378(8):708–718.
  • Stein L, Tuhrim S, Fifi J, et al. National trends in endovascular therapy for acute ischemic stroke: utilization and outcomes. J Neurointerv Surg. 2020 Apr;12(4):356–362.
  • Adeoye O, Hornung R, Khatri P, et al. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011 Jul;42(7):1952–1955.
  • Kleindorfer D, Lindsell CJ, Brass L, et al. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke. 2008 Mar;39(3):924–928.
  • Katzan IL, Hammer MD, Hixson ED, et al. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol. 2004 Mar;61(3):346–350.
  • California Acute Stroke Pilot Registry I. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005 Feb 22;64(4): 654–659.
  • Messe SR, Khatri P, Reeves MJ, et al. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry. Neurology. 2016 Oct 11;87(15):1565–1574.
  • Tilley BC, Lyden PD, Brott TG, et al. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. Arch Neurol. 1997 Dec;54(12):1466–1474.
  • Barber PA, Zhang J, Demchuk AM, et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001 Apr 24;56(8):1015–1020.
  • Berkowitz AL, Mittal MK, McLane HC, et al. Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Int J Stroke. 2014 Apr;9(3):349–355.
  • Shamy MC, Jaigobin CS. The complexities of acute stroke decision-making: a survey of neurologists. Neurology. 2013 Sep 24;81(13):1130–1133.
  • Brown DL, Barsan WG, Lisabeth LD, et al. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med. 2005 Jul;46(1):56–60.
  • Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999 Oct 20;282(15):1458–1465.
  • Aguiar de Sousa D, von Martial R, Abilleira S, et al. Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. Eur Stroke J. 2019 Mar;4(1):13–28.
  • Sharma VK, Ng KW, Venketasubramanian N, et al. Current status of intravenous thrombolysis for acute ischemic stroke in Asia. Int J Stroke. 2011 Dec;6(6):523–530.
  • Zhou Y, Yan S, Song X, et al. Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers. BMC Neurol. 2019 Aug 22;19(1):202.
  • Baatiema L, Chan CKY, Sav A, et al. Interventions for acute stroke management in Africa: a systematic review of the evidence. Syst Rev. 2017 Oct 24;6(1):213.
  • Schwamm LH, Pancioli A, Acker JE 3rd, et al. Recommendations for the establishment of stroke systems of care: recommendations from the American stroke association’s task force on the development of stroke systems. Stroke. 2005 Mar;36(3):690–703.
  • Alberts MJ, Hademenos G, Latchaw RE, et al. Recommendations for the establishment of primary stroke centers Brain attack coalition JAMA. 2000 Jun 21;283(23):3102–3109.
  • Prabhakaran S, McNulty M, O’Neill K, et al. Intravenous thrombolysis for stroke increases over time at primary stroke centers. Stroke. 2012 Mar;43(3):875–877.
  • Gropen TI, Gagliano PJ, Blake CA, et al. Quality improvement in acute stroke: the New York State stroke center designation project. Neurology. 2006 Jul 11;67(1):88–93.
  • Xian Y, Holloway RG, Chan PS, et al. Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA. 2011 Jan 26;305(4):373–380.
  • Mullen MT, Kasner SE, Kallan MJ, et al. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample. J Am Heart Assoc. 2013 Mar 26;2(2):e000071.
  • Parker C, Schwamm LH, Fonarow GC, et al. Stroke quality metrics: systematic reviews of the relationships to patient-centered outcomes and impact of public reporting. Stroke. 2012 Jan;43(1):155–162.
  • Schwamm LH, Fonarow GC, Reeves MJ, et al. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009 Jan 6;119(1):107–115.
  • Ali SF, Singhal AB, Viswanathan A, et al. Characteristics and outcomes among patients transferred to a regional comprehensive stroke center for tertiary care. Stroke. 2013 Nov;44(11):3148–3153.
  • Kamal N, Sheng S, Xian Y, et al. Delays in door-to-needle times and their impact on treatment time and outcomes in get with the guidelines-stroke. Stroke. 2017 Apr;48(4):946–954.
  • Hsieh FI, Lien LM, Chen ST, et al. Get with the guidelines-stroke performance indicators: surveillance of stroke care in the taiwan stroke registry: get with the guidelines-stroke in Taiwan. Circulation. 2010 Sep 14;122(11):1116–1123.
  • Quain DA, Parsons MW, Loudfoot AR, et al. Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care. Med J Aust. 2008 Oct 20;189(8):429–433.
  • Chan YF, Kwiatkowski TG, Rella JG, et al. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective. J Emerg Med. 2005 Nov;29(4):405–408.
  • Tahtali D, Bohmann F, Rostek P, et al. Setting up a stroke team algorithm and conducting simulation-based training in the emergency department - a practical guide. J Vis Exp. 2017 Jan;15(119). doi: 10.3791/55138.
  • Douglas VC, Tong DC, Gillum LA, et al. Do the Brain Attack Coalition’s criteria for stroke centers improve care for ischemic stroke? Neurology. 2005 Feb 8;64(3):422–427.
  • Lellis JC, Brice JH, Evenson KR, et al. Launching online education for 911 telecommunicators and EMS personnel: experiences from the north carolina rapid response to stroke project. Prehosp Emerg Care. 2007 Jul-Sep;11(3):298–306.
  • Wojner-Alexandrov AW, Alexandrov AV, Rodriguez D, et al. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke. 2005 Jul;36(7):1512–1518.
  • Caminiti C, Schulz P, Marcomini B, et al. Development of an education campaign to reduce delays in pre-hospital response to stroke. BMC Emerg Med. 2017 Jun 24;17(1):20.
  • Dowswell G, Forster A, Young J, et al. The development of a collaborative stroke training programme for nurses. J Clin Nurs. 1999 Nov;8(6):743–752.
  • Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/american stroke association. Stroke. 2019 Dec;50(12):e344–e418.
  • Glober NK, Sporer KA, Guluma KZ, et al. Acute stroke: current evidence-based recommendations for prehospital care. West J Emerg Med. 2016 Mar;17(2):104–128.
  • Berglund A, Svensson L, Wahlgren N, et al. Face arm speech time test use in the prehospital setting, better in the ambulance than in the emergency medical communication center. Cerebrovasc Dis. 2014;37(3):212–216.
  • De Luca A, Giorgi Rossi P, Villa GF, et al. The use of cincinnati prehospital stroke scale during telephone dispatch interview increases the accuracy in identifying stroke and transient ischemic attack symptoms. BMC Health Serv Res. 2013;13:513.
  • Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016 Feb;47(2):581–641.
  • Tsivgoulis G, Safouris A, Alexandrov AV. Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions. Expert Opin Drug Saf. 2015 Jun;14(6):845–864.
  • Sandercock P, Wardlaw JM, Lindley RI, et al. group ISTc. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012 Jun 23;379(9834):2352–2363.
  • Chausson N, Soumah D, Aghasaryan M, et al. Reversal of vitamin k antagonist therapy before thrombolysis for acute ischemic stroke. Stroke. 2018 Oct;49(10):2526–2528.
  • Shahjouei S, Tsivgoulis G, Goyal N, et al. Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: a systematic review and meta-analysis. Stroke. 2020 Feb;51(2):533–541.
  • Jin C, Huang RJ, Peterson ED, et al. Intravenous tPA (tissue-type plasminogen activator) in patients with acute ischemic stroke taking non-vitamin k antagonist oral anticoagulants preceding stroke. Stroke. 2018 Sep;49(9):2237–2240.
  • Schwamm LH, Holloway RG, Amarenco P, et al. A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American heart association/American stroke association. Stroke. 2009 Jul;40(7):2616–2634.
  • Amorim E, Shih MM, Koehler SA, et al. Impact of telemedicine implementation in thrombolytic use for acute ischemic stroke: the University of Pittsburgh Medical Center telestroke network experience. J Stroke Cerebrovasc Dis. 2013 May;22(4):527–531.
  • Silva GS, Schwamm LH. Use of telemedicine and other strategies to increase the number of patients that may be treated with intravenous thrombolysis. Curr Neurol Neurosci Rep. 2012 Feb;12(1):10–16.
  • Silva GS, Farrell S, Shandra E, et al. The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke. 2012 Aug;43(8):2078–2085.
  • Nelson RE, Saltzman GM, Skalabrin EJ, et al. The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology. 2011 Oct 25;77(17):1590–1598.
  • Demaerschalk BM, Hwang HM, Leung G. Cost analysis review of stroke centers, telestroke, and rt-PA. Am J Manag Care. 2010 Jul;16(7):537–544.
  • Switzer JA, Demaerschalk BM. Overcoming challenges to sustain a telestroke network. J Stroke Cerebrovasc Dis. 2012 Oct;21(7):535–540.
  • French B, Day E, Watkins C, et al. The challenges of implementing a telestroke network: a systematic review and case study. BMC Med Inform Decis Mak. 2013 Nov;14(13):125. .
  • Fassbender K, Walter S, Liu Y, et al. “Mobile stroke unit” for hyperacute stroke treatment. Stroke. 2003 Jun;34(6):e44. .
  • Wu TC, Parker SA, Jagolino A, et al. Telemedicine can replace the neurologist on a mobile stroke unit. Stroke. 2017 Feb;48(2):493–496.
  • Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a prehospital acute neurological treatment and optimization of medical care in stroke (PHANTOM-S) substudy. JAMA Neurol. 2015 Jan;72(1):25–30.
  • Ebinger M, Winter B, Wendt M, et al. Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA. 2014 Apr 23–30;311(16):1622–1631.
  • Bowry R, Parker S, Rajan SS, et al. Benefits of Stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU study run-in phase. Stroke. 2015 Dec;46(12):3370–3374.
  • John S, Stock S, Masaryk T, et al. Performance of CT angiography on a mobile stroke treatment unit: implications for triage. J Neuroimaging. 2016 Jul;26(4):391–394.
  • Lima FO, Mont’Alverne FJA, Bandeira D, et al. Pre-hospital assessment of large vessel occlusion strokes: implications for modeling and planning stroke systems of care. Front Neurol. 2019;10:955.
  • Rajan SS, Baraniuk S, Parker S, et al. Implementing a mobile stroke unit program in the United States: why, how, and how much? JAMA Neurol. 2015 Feb;72(2):229–234.
  • Walter S, Grunwald IQ, Helwig SA, et al. Mobile stroke units - cost-effective or just an expensive hype? Curr Atheroscler Rep. 2018 Aug 29;20(10):49.
  • Dietrich M, Walter S, Ragoschke-Schumm A, et al. Is prehospital treatment of acute stroke too expensive? An economic evaluation based on the first trial. Cerebrovasc Dis. 2014;38(6):457–463.
  • Kleindorfer D, Khoury J, Broderick JP, et al. Temporal trends in public awareness of stroke: warning signs, risk factors, and treatment. Stroke. 2009 Jul;40(7):2502–2506.
  • Bray JE, Mosley I, Bailey M, et al. Stroke public awareness campaigns have increased ambulance dispatches for stroke in Melbourne, Australia. Stroke. 2011 Aug;42(8):2154–2157.
  • Mellon L, Hickey A, Doyle F, et al. Can a media campaign change health service use in a population with stroke symptoms? Examination of the first Irish stroke awareness campaign. Emerg Med J. 2014 Jul;31(7):536–540.
  • Flynn D, Ford GA, Rodgers H, et al. A time series evaluation of the FAST national stroke awareness campaign in England. PLoS One. 2014;9(8):e104289.
  • Wolters FJ, Paul NL, Li L, et al. Sustained impact of UK FAST-test public education on response to stroke: a population-based time-series study. Int J Stroke. 2015 Oct;10(7):1108–1114.
  • Wolters FJ, Li L, Gutnikov SA, et al. Medical attention seeking after transient ischemic attack and minor stroke before and after the UK Face, Arm, Speech, Time (FAST) public education campaign: results from the oxford vascular study. JAMA Neurol. 2018 Oct 1;75(10):1225–1233.
  • Marx JJ, Gube C, Faldum A, et al. An educational multimedia campaign improves stroke knowledge and risk perception in different stroke risk groups. Eur J Neurol. 2009 May;16(5):612–618.
  • Wall HK, Beagan BM, O’Neill J, et al. Addressing stroke signs and symptoms through public education: the Stroke Heroes Act FAST campaign. Prev Chronic Dis. 2008 Apr;5(2):A49.
  • Kleindorfer D, Miller R, Sailor-Smith S, et al. The challenges of community-based research: the beauty shop stroke education project. Stroke. 2008 Aug;39(8):2331–2335.
  • Williams O, Leighton-Herrmann Quinn E, Teresi J, et al. Improving community stroke preparedness in the HHS (Hip-Hop Stroke) randomized clinical trial. Stroke. 2018 Apr;49(4):972–979.
  • Maas MB, Singhal AB. Unwitnessed stroke: impact of different onset times on eligibility into stroke trials. J Stroke Cerebrovasc Dis. 2013 Apr;22(3):241–243.
  • Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke. 2002 Sep;33(9):2206–2210.
  • Jiang Q, Chopp M, Zhang ZG, et al. The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat. J Neurol Sci. 1997 Jan;145(1):15–23.
  • Knight RA, Dereski MO, Helpern JA, et al. Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke. 1994 Jun;25(6):1252–1261. discussion 1261-2. .
  • Thomalla G, Cheng B, Ebinger M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol. 2011 Nov;10(11):978–986.
  • Thomalla G, Rossbach P, Rosenkranz M, et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol. 2009 Jun;65(6):724–732.
  • Welch KM, Windham J, Knight RA, et al. A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke. 1995 Nov;26(11):1983–1989.
  • Aoki J, Kimura K, Iguchi Y, et al. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci. 2010 Jun 15;293(1–2):39–44.
  • Schwamm LH, Wu O, Song SS, et al. Intravenous thrombolysis in unwitnessed stroke onset: MR WITNESS trial results. Ann Neurol. 2018 May;83(5):980–993.
  • Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018 Aug 16;379(7):611–622.
  • Shih LC, Saver JL, Alger JR, et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke. 2003 Jun;34(6):1425–1430.
  • Wintermark M, Albers GW, Broderick JP, et al. Acute stroke imaging research roadmap II. Stroke. 2013 Sep;44(9):2628–2639.
  • Wu O, Christensen S, Hjort N, et al. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain. 2006 Sep;129(Pt 9):2384–2393.
  • Albers GW, Thijs VN, Wechsler L, et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006 Nov;60(5):508–517.
  • Hellier KD, Hampton JL, Guadagno JV, et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):417–419.
  • Rostrup E, Knudsen GM, Law I, et al. The relationship between cerebral blood flow and volume in humans. Neuroimage. 2005 Jan 1;24(1):1–11.
  • Campbell BC, Christensen S, Levi CR, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke. 2011 Dec;42(12):3435–3440.
  • Boned S, Padroni M, Rubiera M, et al. Admission CT perfusion may overestimate initial infarct core: the ghost infarct core concept. J Neurointerv Surg. 2017 Jan;9(1):66–69.
  • Lui YW, Tang ER, Allmendinger AM, et al. Evaluation of CT perfusion in the setting of cerebral ischemia: patterns and pitfalls. AJNR Am J Neuroradiol. 2010 Oct;31(9):1552–1563.
  • Schramm P, Schellinger PD, Klotz E, et al. Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours’ duration. Stroke. 2004 Jul;35(7):1652–1658.
  • Schaefer PW, Barak ER, Kamalian S, et al. Quantitative assessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged. Stroke. 2008 Nov;39(11):2986–2992.
  • Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke. 2002 Aug;33(8):2025–2031.
  • Copen WA, Yoo AJ, Rost NS, et al. In patients with suspected acute stroke, CT perfusion-based cerebral blood flow maps cannot substitute for DWI in measuring the ischemic core. PLoS One. 2017;12(11):e0188891.
  • Knoepfli AS, Sekoranja L, Bonvin C, et al. Evaluation of perfusion CT and TIBI grade in acute stroke for predicting thrombolysis benefit and clinical outcome. J Neuroradiol. 2009 Jun;36(3):131–137.
  • Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019 May 9;380(19):1795–1803.
  • Coutts SB, Berge E, Campbell BC, et al. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials. Int J Stroke. 2018 Dec;13(9):885–892.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.